Intellia Therapeutics
Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments. It can positively transform the lives of people living with severe and life-threatening diseases. IIntellia holds exclusive access to one of the most comprehensive intellectual property platforms available for the therapeutic use of CRISPR-Cas9. The company is advancing a broad pipeline toward clinical development, including ex Vivo, and in vivo approaches. Intellia Therapeutics was formed in 2014 and is headquartered in Cambridge, Massachusetts.
Domain
intelliatx.com
Country
United StatesIndustry
BiotechnologyEmployees
251-500
Last Funding
$300.0M
Founded
2013
Tech Stack (27 technologies)
Frequently Asked Questions
What technologies does Intellia Therapeutics use?+
Intellia Therapeutics uses 27 technologies including Cookiebot, Fathom, Google Analytics.
What industry is Intellia Therapeutics in?+
Intellia Therapeutics operates in the Biotechnology industry.
Where is Intellia Therapeutics based?+
Intellia Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026